IRIS
TARRICONE, ROSANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.465
NA - Nord America 7.336
AS - Asia 1.862
AF - Africa 83
SA - Sud America 55
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 43
Totale 23.894
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 8.330
US - Stati Uniti d'America 6.883
IE - Irlanda 1.811
GB - Regno Unito 1.279
UA - Ucraina 923
CN - Cina 810
SE - Svezia 477
CA - Canada 425
DE - Germania 395
FI - Finlandia 301
VN - Vietnam 271
FR - Francia 252
TR - Turchia 198
HK - Hong Kong 156
IN - India 137
BG - Bulgaria 136
BE - Belgio 88
KR - Corea 62
RU - Federazione Russa 57
CZ - Repubblica Ceca 50
NL - Olanda 50
KZ - Kazakistan 48
CH - Svizzera 44
AU - Australia 42
DK - Danimarca 42
EU - Europa 40
ES - Italia 37
IR - Iran 29
GR - Grecia 27
RO - Romania 27
JP - Giappone 26
PL - Polonia 24
PT - Portogallo 24
AL - Albania 23
BR - Brasile 23
TH - Thailandia 22
AT - Austria 19
MX - Messico 19
SG - Singapore 18
ZA - Sudafrica 16
MA - Marocco 15
EG - Egitto 14
JO - Giordania 13
CO - Colombia 10
ID - Indonesia 10
PH - Filippine 10
TW - Taiwan 10
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
NZ - Nuova Zelanda 8
AR - Argentina 7
LT - Lituania 7
CL - Cile 6
IL - Israele 5
IQ - Iraq 5
LV - Lettonia 5
MU - Mauritius 5
MY - Malesia 5
BY - Bielorussia 4
EC - Ecuador 4
NG - Nigeria 4
NO - Norvegia 4
PA - Panama 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
SM - San Marino 4
ET - Etiopia 3
GH - Ghana 3
HU - Ungheria 3
KE - Kenya 3
LU - Lussemburgo 3
MT - Malta 3
MW - Malawi 3
PK - Pakistan 3
SA - Arabia Saudita 3
SI - Slovenia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CR - Costa Rica 2
DZ - Algeria 2
GE - Georgia 2
GG - Guernsey 2
HN - Honduras 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MC - Monaco 2
MD - Moldavia 2
SD - Sudan 2
A1 - Anonimo 1
AD - Andorra 1
AM - Armenia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BO - Bolivia 1
CD - Congo 1
CM - Camerun 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
Totale 23.890
Salva come PNG Salva come JPEG
Città #
Dublin 1.798
Milan 1.218
Chandler 1.161
Jacksonville 749
Rome 675
Southend 628
Ann Arbor 522
Toronto 379
Dearborn 337
Dong Ket 237
New York 235
Beijing 227
Houston 222
Wilmington 214
Lawrence 183
Helsinki 168
Izmir 163
Ashburn 162
Boston 161
Modena 147
Redmond 139
Hong Kong 137
Turin 133
Mountain View 124
Redwood City 121
Boardman 118
Naples 105
Bologna 98
Woodbridge 88
Florence 76
Brussels 71
Bari 68
Fairfield 62
Seattle 60
Seoul 56
Hefei 53
Catania 50
Palombara Sabina 50
Almaty 47
Napoli 46
Padova 45
Nanjing 44
Falls Church 42
Los Angeles 42
Genoa 41
Kunming 40
Palermo 40
Trieste 35
Duncan 34
London 32
Perugia 31
Saint Petersburg 30
Torino 30
Brescia 27
Dallas 27
Taranto 27
Fremont 26
Jinan 26
Washington 26
Cagliari 25
Livorno 25
Pescara 25
Monza 24
Paris 24
Pisa 24
Messina 23
Verona 23
Genova 22
Norwalk 22
Latina 21
Trento 20
Udine 20
Ancona 19
Bergamo 19
Pavia 19
Treviso 19
Venezia 19
Lucca 18
Sassari 18
Guangzhou 17
Robbiate 17
Sabbioneta 17
Busto Arsizio 16
Dalmine 16
Nanchang 16
Nardò 16
Salerno 16
San Mateo 16
Athens 15
Auburn Hills 15
Bonndorf 15
Lisbon 15
Campobasso 14
Foggia 14
Novara 14
Vicenza 14
Ferrara 13
Hebei 13
Ottawa 13
Parma 13
Totale 12.677
Salva come PNG Salva come JPEG
Nome #
Analisi dei costi della procedura angioplastica coronarica per via transradiale in regime ambulatoriale in Italia 3.049
Misurare le performance per creare valore nelle aziende sanitarie pubbliche: uno strumento multidimensionale di valutazione 1.877
Economic Evaluation for Devices and Drugs-Same or Different? 430
Impact of a probiotic-based hospital sanitation on antimicrobial resistance and HAI-associated antimicrobial consumption and costs: a multicenter study 406
La funzione di HTA nelle aziende sanitarie italiane: un potenziale ancora inutilizzato? 293
Prezzi di riferimento per dispositivi medici: criticità, vantaggi e approcci 274
Impatto economico dell'utilizzo di carbossimaltosio ferrico in pazienti con anemia di carenza di ferro nelle regioni italiane 254
PDTA per la chirurgia bariatrica: l'esperienza di 6 centri italiani 248
Innovazione e competitività nei sistemi industriali regolati : le imprese dei dispositivi medici 239
Esiti di salute e performance del Servizio Sanitario Nazionale 236
Metodologia di indagine e primi risultati sul costo sociale della depressione maggiore in Italia 233
Lo sviluppo dell'Health Technology Assessment in Italia: contenuti, approcci e riferimenti internazionali 226
Il miglioramento del performance management nelle aziende sanitarie pubbliche: oltre le mode e le tradizioni 221
Valutazioni economiche e management in sanità. Applicazioni ai programmi e tecnologie sanitarie 217
I dispositivi medici in Italia: un settore, tanti mercati 204
Dinamiche economiche e performance del settore dei dispositivi medici in Italia 194
Basic principles of health technology assessment, economic evaluation, and costing of healthcare programs 188
Programma nazionale HTA per dispositivi medici: quali sfide per l’implementazione? 186
Le imprese produttrici di dispositivi medici e le caratteristiche del prodotto e del mercato 167
Economic evaluation of medical devices 166
Programma Nazionale di HTA per dispositivi medici: prove tecniche di implementazione 165
Gli esiti di salute del Servizio Sanitario Nazionale 162
Initiatives to improve control, resource use, and quality of life associated with chemotherapy-induced nausea and vomiting 162
Public Versus Private Financing 151
Approccio value-based e logiche di finanziamento: implicazioni per le politiche di rimborsabilità in sanità 150
Current and Future Trends in the HTA of Medical Devices 148
De innovatione: the concept of innovation for medical technologies and its implications for healthcare policy-making 148
Impatto del sistema di finanziamento a DRG sull’innovazione tecnologica in sanità. Il caso italiano 147
Real-world data for the evaluation of transarterial radioembolization versus sorafenib in hepatocellular carcinoma: a cost-effectiveness analysis 147
Real-world cost effectiveness of MitraClip combined with medical therapy versus medical therapy alone in patients with moderate or severe mitral regurgitation 145
The impact of HTA and procurement practices on the selection and prices of medical devices 142
Il governo dell’innovazione tecnologica in sanità. Il caso dell’impianto di valvola aortica transcatetere: stato dell’arte delle indicazioni e della rimborsabilità nelle regioni italiane 141
Tempi di attesa: trend e politiche di risposta durante e dopo la crisi Covid-19 140
Gli esiti di salute del Servizio Sanitario Nazionale 139
Myth #5: health care is rightly left to the private sector, for the sake of efficiency 138
Il costo sociale della schizofrenia. Una rassegna ragionata della bibliografia 131
Learning effect and diffusion of innovative medical devices: the case of transcatheter aortic valve implantation in Italy 129
Diffusion without evidence: a study on high-risk medical devices 129
Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia 126
Do social values and institutional context shape the use of economic evaluation in reimbursement decisions? An empirical analysis 126
The Lung Cancer App (LuCApp) study protocol: a randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancer 126
Sustainability of Universal Health Coverage: Five Continents, Four Perspectives 125
Challenges in the assessment of medical devices: the MedtecHTA Project 122
Key reccomendations from the MedtecHTA project 119
Direct costs of intracranial aneurysm treatment in the Italian hospitals 117
Validation of the underlying assumptions of the quality-adjusted life-years outcome: results from the ECHOUTCOME European project 117
A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer 116
Valutazione di Health Technology Assessment del sistema di sanificazione biologico a base di probiotici del genere Bacillus (PCHS) 115
Integrating HTA principles into procurement of medical devices: the Italian national HTA programme for medical devices 113
Comparative effectiveness of Mitraclip plus medical therapy versus medical therapy alone in high-risk surgical patients: a comprehensive review 112
Trans-arterial radioembolization in intermediate-advanced hepatocellular carcinoma: systematic review and meta-analyses 112
Does the approach to economic evaluation in health care depend on culture, values, and institutional context? 112
L'adozione dell'innovazione tecnologica da parte degli ospedali italiani: un'analisi dei fattori endogeni 111
Improving the methods for the economic evaluation of medical devices 110
The evolution of the Italian National Health Service 107
Valutazione economica della prevenzione con misoprostol della gastropatia da farmaci anti-infiammatori non steoridei in italia 105
Influence of sanitizing methods on healthcare-associated infections onset: a multicentre, randomized, controlled pre-post interventional study. 105
Valutare l’impatto dell’HTA come strumento di governo dell’innovazione tecnologica: modelli teorici e studi empirici 105
Analisi costi-efficacia della cura del dolore in Italia: la radioisotopoterapia con Samario-153 e la terapia convenzionale 105
I costi ospedalieri dell'ictus in Italia: un confronto tra diversi modelli di cura 104
Comparing drug and non-drug technologies in comparative effectiveness research 103
Planning and control of medical device investments by Italian public health authorities: a means to improve the decision-making process 102
Core outcome set in surgical oncology: why, what and how to measure 102
Costing and performance in healthcare management 101
Analisi costi-efficacia della cura del dolore in Italia: la radioisotopoterapia con Samario-153 e la terapia convenzionale 100
An economic perspective on urinary tract infection: the "costs of resignation" 100
Economic evidence of interventions for acute myocardial infarction: a review of the literature 99
Cost–effectiveness analysis of treatments involving radioembolization in intermediate-stage hepatocellular carcinoma 98
Diffusion and use of Health Technology Assessment in policy making: what lessons for decentralised healthcare systems? 98
Clinical outcomes and quality of life associated with the use of a biosynthetic mesh for complex ventral hernia repair: analysis of the “Italian Hernia Club” registry 97
Mobile health divide between clinicians and patients in cancer care: results from a cross-sectional international survey 97
Controllo delle infezioni ospedaliere attraverso un sistema di sanificazione a base di probiotici: valutazione clinica ed economica 97
Harmonization of health technology assessment across the European Union: lessons for the United States 97
Prognostic Value of the Cell Cycle Progression Score in Patients with Prostate Cancer: A Systematic Review and Meta-analysis 96
Budget impact analysis of a biosynthetic mesh for incisional hernia repair 96
What type of clinical evidence is needed to assess medical devices? 96
Measuring value in health care: a comparative analysis of value-based frameworks 96
Should health technology assessment be more patient centric? If so, how? 96
European diabetes research and its funding, 2002–2013 95
Cost-effectiveness for trigeminal neuralgia: Cyberknife vs microvascular decompression 94
Applying Health Economics for Policy Decision Making: Do Devices Differ From Drugs? 94
Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: a systematic review 94
Healthcare resource consumption for intermittent urinary catheterisation: cost-effectiveness of hydrophilic catheters and budget impact analyses 94
Genetic Screening for the Predisposition to Venous Thromboembolism: A Cost-Utility Analysis of Clinical Practice in the Italian HealthCare System 94
Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis 94
Distinguishing features in the assessment of mHealth apps 93
Il sistema assicurativo sanitario olandese 92
Assessing the added value of health technologies: reconciling different perspectives 92
Prefazione 92
Cost-benefit analysis in health care: the case of bariatric surgery compared with diet 92
Establishing a national HTA program for medical devices in Italy: overhauling a fragmented system to ensure value and equal access to new medical technologies 92
COI analysis: what room in health economics? 91
The rise of rules: will the new regulation of medical devices make us safer? 91
Terapia dell'ictus: valutazione economica e modelli organizzativi 91
Systematic review of urinary incontinence and overactive bladder cost-of-illness studies 91
Challenges in the clinical and economic evaluation of medical devices: the case of transcathether aortic valve implantation 90
Characterising uncertainty in the assessment of medical devices and determining future research needs 90
State-of-the-art of abdominal wall surgery in Italy: coding, reimbursement, hospitalisations and expenditure for surgical meshes 88
L'analisi di costo sociale. Quale ruolo per il management e l'economia sanitaria? 87
Determinants of demand for total hip and and knee arthroplasty: a systematic literature review 87
Totale 18.221
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.015
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.015
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019332 0 0 0 0 0 0 0 0 0 0 87 245
2019/20203.701 149 55 243 205 300 516 639 310 343 369 283 289
2020/20213.429 183 274 138 303 381 247 322 171 368 235 353 454
2021/20223.203 202 451 125 167 261 156 163 521 238 257 325 337
2022/20237.126 385 371 200 603 522 561 304 509 2.560 320 441 350
2023/20243.961 327 264 351 235 439 543 474 595 304 357 72 0
Totale 24.427